AI vs. Offshore: The Real Cost Comparison

Automate intake, eligibility, and PA with AI agents that work in your EMR and billing systems.

Contact us to get started

Create a free account to automate medical coding. Just upload a chart and get codes.

Create Free Account
Search all medical codes

Hormone sensitive malignancy status

ICD10CM code

Medical Policies and Guidelines for Hormone sensitive malignancy status

Related policies from health plans

Gamma Glutamyl Transferase Testing
Outpatient Laboratory-based Blood Glucose Testing
Outpatient Urine Culture
Thyroid Testing
CG-LAB-20 Thyroid Testing
CG-LAB-24 Outpatient Urine Culture
CG-LAB-29 Gamma Glutamyl Transferase Testing
CG-LAB-30 Outpatient Laboratory-based Blood Glucose Testing
Transthoracic Echocardiography in Children - (0523)

Similar Codes


ICD10CM codes

Z19.1 - Hormone sensitive malignancy status
Z19 - Hormone sensitivity malignancy status
Z19.2 - Hormone resistant malignancy status
Z17 - Estrogen receptor status
Z85 - Personal history of malignant neoplasm
Z85.85 - Personal history of malignant neoplasm of endocrine glands
Z85.9 - Personal history of malignant neoplasm, unspecified
Z85.3 - Personal history of malignant neoplasm of breast
Z12.3 - Encounter for screening for malignant neoplasm of breast
Z15.0 - Genetic susceptibility to malignant neoplasm

HCPCS codes

G9842 - Patient has metastatic disease at diagnosis
G9097 - Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as
G8875 - Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
G9552 - Incidental thyroid nodule < 1.0 cm noted in report
D7430 - Excision of benign tumor-lesion diameter up to 1.25 cm
G8721 - Pt category (primary tumor), pn category (regional lymph nodes), and histologic grade were documente
D0190 - Screening of a patient
G9618 - Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial
D0191 - Assessment of a patient
G9549 - Documentation of medical reason(s) that follow-up imaging is indicated (e.g., patient has lymphadeno

CPT4 codes

3374F - AJCC Breast Cancer Stage I: T1c (tumor size > 1 cm to 2 cm) documented (ONC)
3344F - Mammogram assessment category of suspicious, documented (RAD)
3315F - Estrogen receptor (ER) or progesterone receptor (PR) positive breast cancer (ONC)
81500 - Oncology (ovarian), biochemical assays of two proteins (CA-125 and HE4), utilizing serum, with menop
3316F - Estrogen receptor (ER) and progesterone receptor (PR) negative breast cancer (ONC)
3342F - Mammogram assessment category of benign, documented (RAD)
3388F - AJCC colon cancer, Stage III documented (ONC)
58956 - Bilateral salpingo-oophorectomy with total omentectomy, total abdominal hysterectomy for malignancy
0045U - Oncology (breast ductal carcinoma in situ), mRNA, gene expression profiling by real-time RT-PCR of 1
1150F - Documentation that a patient has a substantial risk of death within 1 year (Pall Cr)